Chargement en cours...
A comparison between the administration of oral prolonged-release oxycodone-naloxone and transdermal fentanyl in patients with moderate-to-severe cancer pain: a propensity score analysis
BACKGROUND: Opioids are the most important pharmacological treatment for moderate-to-severe cancer pain, but side effects limit their use. Transdermal fentanyl (TDF) and oral prolonged-release oxycodone-naloxone (OXN-PR) are effective in controlling chronic pain, with less constipation compared to o...
Enregistré dans:
| Publié dans: | J Pain Res |
|---|---|
| Auteurs principaux: | , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Dove Medical Press
2017
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5590764/ https://ncbi.nlm.nih.gov/pubmed/28919810 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/JPR.S141928 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|